Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar A Santa-Maria

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Cancer Survivorship : Research and Practice|May 21, 2021
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remoteJennifer Y Sheng, Cesar A Santa-Maria, Amanda L Blackford, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2022
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapyMadelyn Whitaker, Whitney A Welch, Jason Fanning, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2019
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancerPayton Solk, Kara Gavin, Jason Fanning, et al.
Journal of the National Cancer Institute|August 13, 2008
Residual risk of breast cancer recurrence 5 years after adjuvant therapyAbenaa M Brewster, Gabriel N Hortobagyi, Kristine R Broglio, et al.
Clinical Breast Cancer|January 9, 2023
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain MetastasesAmi N Shah, Cesar A Santa-Maria, Dhruvika Mukhija, et al.
Nature Cancer|July 5, 2022
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancerLaura M Spring, Hyo Han, Minetta C Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 30, 2020
Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal ExaminationSiobhan M Phillips, Whitney A Welch, Jason Fanning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2015
Targeting Glutamine Metabolism in Breast Cancer with AminooxyacetatePreethi Korangath, Wei Wen Teo, Helen Sadik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE DataFrederick M Howard, Peter A Fasching, Cesar A Santa-Maria, et al.
Nature Communications|September 28, 2024
Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-CInês Godet, Harsh H Oza, Yi Shi, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Cancer Survivorship : Research and Practice|May 21, 2021
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remoteJennifer Y Sheng, Cesar A Santa-Maria, Amanda L Blackford, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2022
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapyMadelyn Whitaker, Whitney A Welch, Jason Fanning, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2019
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancerPayton Solk, Kara Gavin, Jason Fanning, et al.
Journal of the National Cancer Institute|August 13, 2008
Residual risk of breast cancer recurrence 5 years after adjuvant therapyAbenaa M Brewster, Gabriel N Hortobagyi, Kristine R Broglio, et al.
Clinical Breast Cancer|January 9, 2023
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain MetastasesAmi N Shah, Cesar A Santa-Maria, Dhruvika Mukhija, et al.
Nature Cancer|July 5, 2022
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancerLaura M Spring, Hyo Han, Minetta C Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 30, 2020
Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal ExaminationSiobhan M Phillips, Whitney A Welch, Jason Fanning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2015
Targeting Glutamine Metabolism in Breast Cancer with AminooxyacetatePreethi Korangath, Wei Wen Teo, Helen Sadik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE DataFrederick M Howard, Peter A Fasching, Cesar A Santa-Maria, et al.
Nature Communications|September 28, 2024
Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-CInês Godet, Harsh H Oza, Yi Shi, et al.
Pageof 6